Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 8, 2025

November 8, 2025

Dr. Thumbay Moideen Honored Among the Top 100 Muslims in the World

EIN Presswire

November 8, 2025

Atlantic Spine Center and MD360 Introduce AI-Powered Pain Evaluation Tool, Pioneering a Smarter Approach to Spine Care

EIN Presswire

November 8, 2025

KFSHRC Showcases Digital Leadership in Healthcare Innovation at Milken Institute Future of Health Summit 2025

EIN Presswire

November 8, 2025

KFSHRC Highlights Saudi Arabia’s Rising Role in Global Biotech at Milken Institute Future of Health Summit 2025

EIN Presswire

November 8, 2025

Ainnocence Expands the Druggable Universe: Targeting Therapeutics without Structural Data

EIN Presswire

November 8, 2025

Proactive MD Expands Urgent Care Access with New Acquisitions

EIN Presswire

November 8, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire

November 8, 2025

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

GlobeNewswire

November 8, 2025

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

GlobeNewswire

November 8, 2025

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

GlobeNewswire

November 8, 2025

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

GlobeNewswire

November 8, 2025

Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates

GlobeNewswire

November 8, 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

GlobeNewswire

November 8, 2025

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

GlobeNewswire

November 8, 2025

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

GlobeNewswire

November 8, 2025

Dancetime Launches Guide to Top 8 Outdoor Party Hire Essentials Amid Surge in Sydney Events

GlobeNewswire

November 8, 2025

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

GlobeNewswire

November 8, 2025

Lavnlux Introduces The Porto, a Patented Luxury Spa and Shower Innovation

EIN Presswire

November 8, 2025

MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era

GlobeNewswire

November 8, 2025

Minervate Elevates Global Clinical Research with AI-Powered Compliance Tools at Web Summit 2025

EIN Presswire